Scientist (Mass Spectrometry)
- Employer
- Sutro Biopharma, Inc
- Location
- South San Francisco, CA
- Salary
- $130,000 to $148,000
- Start date
- Jan 28, 2025
View more categoriesView less categories
- Discipline
- Science/R&D, Biotechnology
- Required Education
- Bachelors Degree
- Position Type
- Full time
- Hotbed
- Biotech Bay, Best Places to Work
Job Details
- Independently perform mass spectrometry assays in support of monoclonal antibody-drug conjugate characterization and process development activities, including but not limited to intact, subunit and peptide level analysis.
- Ability to serve as an analytical subject matter expert, represent Research and work closely with colleagues across different functional teams and departments.
- Assist in evaluating new technologies to stay at the cutting edge of biologics discovery, production, and analysis.
- Participate in cross-functional teams at project-related meetings, lead/facilitate technical discussions.
- Maintain and troubleshoot instrumentation, including mass specs, and associated LCs, autosamplers.
- PhD in analytical chemistry, biochemistry, molecular biology, or a related field with 1 to 3 years of industry experience; BS/MS in chemical biology, biochemistry, chemistry, molecular biology, or a related field with over 6 years of experience in characterizing large molecules.
- Demonstrated theoretical and practical understanding of scientific discipline with the ability to learn and master innovative technologies.
- In-depth experience with various mass spectrometry platforms (Orbitrap and Q-ToF), MS workflows for protein characterization, and MS software applications for analyzing both routine and complex data sets.
- Robust analytical knowledge with demonstrated proficiency of various chromatographic and capillary electrophoresis techniques.
- Direct experience with biologics, monoclonal antibodies and/or protein therapeutics is a plus.
- Direct experience in ion mobility technology is a plus.
- Excellent organizational skills with the capacity to manage multiple projects and tasks simultaneously within timelines.
- Goal-oriented team player with excellent verbal and written communication skills and a strong can-do attitude and can operate effectively in a fast-paced, multi-disciplinary environment.
To recruiting firms: Sutro Biopharma does not accept agency resumes and solicitations from third-party agencies. Please do not forward resumes to our hiring managers or employees. Sutro Biopharma is not responsible for any fees related to unsolicited resumes.
The anticipated salary range for fully qualified candidates applying for this role at Sutro Biopharma’s California based locations will be $130,000 to $148,000 (not including bonus, equity, and benefits). The base salary offered will vary depending on the market, job-related knowledge, skills and capabilities, and experience. About Sutro Biopharma Sutro Biopharma, Inc., is a clinical-stage company relentlessly focused on the discovery and development of precisely designed cancer therapeutics, transforming what science can do for patients. Sutro’s fit-for-purpose technology, including cell-free XpressCF®, provides the opportunity for broader patient benefit and an improved patient experience. Sutro has multiple clinical stage candidates, including luveltamab tazevibulin, or luvelta, a registrational-stage folate receptor alpha (FRα)-targeting ADC in clinical studies. A robust pipeline, coupled with high-value collaborations and industry partnerships, validates our continuous product innovation. Sutro is headquartered in South San Francisco. For more information, follow Sutro on social media @Sutrobio, or visit www.sutrobio.com.Company
Sutro Biopharma, Inc., is a clinical-stage company relentlessly focused on the discovery and development of precisely designed cancer therapeutics, transforming what science can do for patients. Sutro’s fit-for-purpose technology, including cell-free XpressCF®, provides the opportunity for broader patient benefit and an improved patient experience. Sutro has multiple clinical stage candidates, including luveltamab tazevibulin, or luvelta, a registrational-stage folate receptor alpha (FolRα)-targeting ADC in clinical studies. A robust pipeline, coupled with high-value collaborations and industry partnerships, validates our continuous product innovation. Sutro is headquartered in South San Francisco. For more information, follow Sutro on social media @Sutrobio, or visit www.sutrobio.com.
Stock Symbol: STRO
Bill Newell, CEO Interviewed by Brad Loncar, Founder, Biotech TV – “Sutro Biopharma’s CEO on ADCs, non-cell protein synthesis, and more" - view it here
- Website
- http://www.sutrobio.com/
- Phone
- 650.881.6500
- Location
-
111 Oyster Point Blvd
South San Francisco
California
94080
US
Get job alerts
Create a job alert and receive personalized job recommendations straight to your inbox.
Create alert